Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Lamins are vital for cell survival, organ development, and preventing premature aging.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

FOXN1 gene variants cause low T cells and immune issues from birth.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Mice with human skin protein K8 had more skin problems and cancer.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The new lab-grown skin model is good for testing sunscreen's protection against DNA damage from UV light.

Using neurohormones to control keratin can lead to new skin disease treatments.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.